Reveal HealthTech raises $7.2m Series A

AI transformation partner Reveal HealthTech has raised US$7.2m in Series A funding to expand its healthcare and life sciences technology.

The funding will support product expansion, sales growth and work with more healthcare and life sciences organisations.

Founded in 2023 and incubated by W Health Ventures and 2070 Health, the company develops artificial intelligence systems for US healthcare and life sciences organisations.

Based in New York and Bangalore, it describes itself as operating at the intersection of AI and clinical expertise.

Its products include BioCanvas, which supports multimodal AI applications such as faster clinical trial recruitment, and Prism AI, which creates automated tools for healthcare workflows.

Sanchit Mullick, founder of Reveal HealthTech, said: “Our mission is simple but bold.

“We want to make AI the most trusted and accountable partner in healthcare, driving breakthroughs for everyone from Fortune 100 pharma companies and large healthcare delivery systems to emerging innovators in digital health.”

The Series A round was led by Leo Capital, with participation from Sanos Capital.

Leo Capital is a venture capital fund investing in early-stage technology companies in the US, India and Europe, with a portfolio of more than 50 companies.

Rajul Garg, partner at Leo Capital, said: “Meeting with Sanchit, Dr Salim, and the AI leadership team at Reveal made it clear their strength lies in crafting tailored solutions that deliver measurable results for clients.

“We’re very excited to support the team in its next phase of growth.”

Garg previously co-founded Pine Labs and GlobalLogic, a design, data and digital engineering company later acquired by Apax Partners.

As part of its expansion strategy, Reveal HealthTech is joining the Cipher Collective, an ECG-powered AI partner network that brings health technology companies together to improve care delivery.